Auna S.A.’s Risk-Sharing Strategy in Colombia Supports Revenue Growth

Auna SA AUNA is focused on improving healthcare delivery in Spanish-speaking Latin America, where the private market remains fragmented and underpenetrated. In this context, Colombia continues to be a key market, both in terms of regional scale and its ability to maintain best practices in patient care and outcomes. Facing continued pressure from government interventions, the company adopted a strategy to limit risk exposure by calibrating growth and focusing on preserving cash flow.

Auna SA reduced its exposure to Nueva EPS, one of the largest government-intervened payers, and shifted its volumes to other payers under risk-sharing models to support liquidity generation.

The progress made in this strategy is visible in the figures. In Q4 2025, Auna SA expanded its risk sharing models such as Prospective Global Payments (“PGP”), which grew by four percentage points to account for 21% of segment revenue. The integration of Salud Total under a new PGP program, alongside the expansion of PGPs, contributed to a 6% increase in revenue in Colombia for the quarter.

Although surgical volumes declined due to fewer services provided to intervening payers, increased surgical tickets and growth in chemotherapy and imaging services more than offset this decline. According to management, the transition to more integrated solutions for payers, doctors and patients helps Auna SA strengthen its presence in Colombia while enabling more predictable reimbursement structures and reducing business volatility.

Although Colombia remains strategically important due to its scale and profitability, the company’s operations in Mexico and Peru are expected to be the main drivers over the next five years, given the enormous growth opportunities.

AUNA Peer Updates

Community Health Systems, Inc. CYH announced that its subsidiary has completed the sale of substantially all of the assets of the 180-bed Crestwood Medical Center in Huntsville, Alabama, and its associated ambulatory care centers and practices, to Huntsville Hospital Health System for $459 million, before certain transaction expenses. Another CYH subsidiary has entered into a definitive agreement to sell four Arkansas hospitals to Freeman Health System for $112 million, subject to certain adjustments based on closing net working capital and the amount of finance leases assumed by the buyer.

Labcorp Holdings LH recently completed the acquisition of selected assets of Crouse Health’s Laboratory Alliance of Central New York (Lab Alliance). The company also entered into a strategic agreement to manage the day-to-day operations of its inpatient laboratory. The transaction is expected to increase access to affordable, high-quality diagnostic services for patients and providers in Central New York through Labcorp’s expanded testing menu, robust data and digital tools such as Diagnostic Assistant and Test Finder.

The Zacks Summary for AUNA Stock

Year to date, Auna shares are up 17.7%, compared to a decline of 12.2% for the industry.

Image Source: Zacks Investment Research

Auna SA trades at a one-year forward price-to-earnings (P/E) of 6.49X, lower than its median and the industry average.

Image Source: Zacks Investment Research

Take a look at how Auna SA’s earnings estimates are trending.

Image Source: Zacks Investment Research

AUNA currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks Research Chief Names ‘Stock Most Likely to Double’

Our team of experts has just published the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Among these 5 titles, research director Sheraz Mian highlights the one that should climb the highest.

This top pick is a little-known satellite communications company. Space is expected to become a billion-dollar industry, and the company’s customer base is growing rapidly. Analysts are forecasting a big rise in revenue in 2025. Of course, not all of our elite picks are winners, but this one could far outperform previous Zacks stocks expected to double, like Hims & Hers Health, which soared +209%.

Free: consult our best stocks and our 4 finalists

Want the latest recommendations from Zacks Investment Research? Today you can download the 7 best stocks for the next 30 days. Click to get this free report

This article was originally published on Zacks Investment Research (zacks.com).

Zacks Investing Research